Lineage Cell Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC | 11/14/2025 | 49.56 M | $83.76 M | 0.00% | 21.70% |
| VANGUARD GROUP INC | 11/07/2025 | 9.01 M | $15.22 M | 6.18% | 3.94% |
| RAFFLES ASSOCIATES LP | 11/14/2025 | 5.39 M | $9.11 M | -0.08% | 2.36% |
| COMERICA BANK | 11/14/2025 | 4.60 M | $7.77 M | 0.00% | 2.01% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 2.68 M | $4.53 M | 3.05% | 1.17% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 2.42 M | $4.09 M | -0.49% | 1.06% |
| BLACKROCK, INC. | 11/12/2025 | 2.23 M | $3.77 M | -1.33% | 0.98% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 1.91 M | $3.22 M | -3.38% | 0.83% |
| DAUNTLESS INVESTMENT GROUP, LLC | 11/14/2025 | 1.61 M | $2.73 M | 33.85% | 0.71% |
| MORGAN STANLEY | 11/14/2025 | 1.01 M | $1.70 M | 20.18% | 0.44% |
| STATE STREET CORP | 11/14/2025 | 955.62 K | $1.62 M | 12.49% | 0.42% |
| GSA CAPITAL PARTNERS LLP | 11/07/2025 | 670.86 K | $1.13 M | -25.26% | 0.29% |
| RED CRANE WEALTH MANAGEMENT, LLC | 10/29/2025 | 511.36 K | $864.20 K | 3.10% | 0.22% |
| NORTHERN TRUST CORP | 11/14/2025 | 443.35 K | $749.26 K | -13.15% | 0.19% |
| EAM INVESTORS, LLC | 11/14/2025 | 442.22 K | $747.35 K | 100.00% | 0.19% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 354.35 K | $598.85 K | 11.44% | 0.16% |
| ROYAL BANK OF CANADA | 11/14/2025 | 306.27 K | $517.00 K | 17.82% | 0.13% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 233.44 K | $394.51 K | 125.95% | 0.10% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 221.00 K | $373.49 K | 47.33% | 0.10% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 218.27 K | $368.88 K | 219.70% | 0.10% |
| UBS GROUP AG | 11/13/2025 | 208.08 K | $351.66 K | -8.58% | 0.09% |
| FMR LLC | 11/13/2025 | 194.03 K | $327.91 K | -0.44% | 0.09% |
| CITADEL ADVISORS LLC | 11/14/2025 | 193.97 K | $327.81 K | 4.58% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 185.00 K | $312.65 K | -66.19% | 0.08% |
| QUADRATURE CAPITAL LTD | 11/13/2025 | 179.03 K | $304.35 K | 100.00% | 0.08% |
| IEQ CAPITAL, LLC | 11/14/2025 | 160.41 K | $271.10 K | 596.24% | 0.07% |
| JANE STREET GROUP, LLC | 11/14/2025 | 144.86 K | $244.82 K | -90.38% | 0.06% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 144.68 K | $244.50 K | -19.71% | 0.06% |
| CITADEL ADVISORS LLC | 11/14/2025 | 118.00 K | $199.42 K | -49.87% | 0.05% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 109.30 K | $184.72 K | 60.03% | 0.05% |
| WILLIAMS JONES WEALTH MANAGEMENT, LLC. | 11/14/2025 | 101.30 K | $171.20 K | 0.00% | 0.04% |
| COMMONWEALTH EQUITY SERVICES, LLC | 10/22/2025 | 100.92 K | $171.00 K | 64.04% | 0.04% |
| HIGHTOWER ADVISORS, LLC | 11/07/2025 | 98.37 K | $166.25 K | 70.47% | 0.04% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 90.38 K | $152.74 K | 30.27% | 0.04% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 84.80 K | $122.93 K | 4.07% | 0.04% |
| SUMMITTX CAPITAL, L.P. | 11/14/2025 | 73.84 K | $124.78 K | -74.23% | 0.03% |
| CATALYST FUNDS MANAGEMENT PTY LTD | 11/12/2025 | 62.40 K | $105.46 K | -24.91% | 0.03% |
| JEFFERIES FINANCIAL GROUP INC. | 11/13/2025 | 62.20 K | $105.12 K | 100.00% | 0.03% |
| FORT SHERIDAN ADVISORS LLC | 11/13/2025 | 55.18 K | $93.25 K | 0.00% | 0.02% |
| CIBC WORLD MARKET INC. | 11/06/2025 | 47.05 K | $79.52 K | 0.00% | 0.02% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 11/14/2025 | 46.82 K | $79.12 K | -57.91% | 0.02% |
| BEIRNE WEALTH CONSULTING SERVICES, LLC | 11/07/2025 | 45.00 K | $76.05 K | 0.00% | 0.02% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2025 | 37.49 K | $63.35 K | -91.39% | 0.02% |
| ORG PARTNERS LLC | 10/24/2025 | 35.70 K | $60.33 K | -39.70% | 0.02% |
| RATHBONES GROUP PLC | 11/13/2025 | 35.00 K | $59.15 K | 0.00% | 0.02% |
| NWAM LLC | 10/28/2025 | 35.00 K | $56.35 K | 133.33% | 0.02% |
| TRUST CO OF TOLEDO NA /OH/ | 10/16/2025 | 33.80 K | $57.11 K | 0.00% | 0.01% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 31.13 K | $52.62 K | 74.96% | 0.01% |
| EQUITABLE HOLDINGS, INC. | 11/14/2025 | 30.02 K | $50.74 K | 100.00% | 0.01% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 29.10 K | $49.18 K | 100.00% | 0.01% |
Lineage Cell Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 170 institutional investors and hedge funds held shares of Lineage Cell Therapeutics, Inc.. The most heavily invested institutionals were:
BROADWOOD CAPITAL INC: 49.56 M
VANGUARD GROUP INC: 9.01 M
RAFFLES ASSOCIATES LP: 5.39 M
COMERICA BANK: 4.6 M
MILLENNIUM MANAGEMENT LLC: 2.68 M
GEODE CAPITAL MANAGEMENT, LLC: 2.42 M
38.50% of Lineage Cell Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 98.49 M shares in the last 24 months. This purchase volume represents approximately $171.86 M in transactions.